tykhr
sign in
free sign up
Contineum Therapeutics, Inc. Class A Common Stock
Biotechnology
Healthcare
CTNM
25.90 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
11.20
52 week high
20.08
high
11.67
52 week low
0.00
low
11.01
growth
-44.25 %
previous Close
11.27
P/E ratio
market cap
204 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-16.04 M
-0.31 %
eps
0.00 %
0.00 %
eps surprise
-121.43 %
net profit margin
-1604000000.00 %
0.00 %
operating incoming
-17.90 M
1.15 %
net change in cash
-1.69 M
-419.92 %
cash on hand
20.78 M
-7.50 %
cost of revenue
79.00 K
0.00 %
top